Results 21 to 30 of about 216,446 (286)

A Spanish value set for the SF-6D based on the SF-12 v1. [PDF]

Eur J Health Econ
This paper reports the first estimation of an SF-6D value set based on the SF-12 for Spain. A representative sample (n = 1020) of the Spanish general population valued a selection of 56 hypothetical SF-6D health states by means of a probability lottery ...
Martínez-Pérez JE, Abellán-Perpiñán JM, Sánchez-Martínez FI, Ruiz-López JJ.   +3 more
europepmc   +2 more sources

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach. [PDF]

J Clin Med, 2022
This study compares EQ-5D-3L, EQ-5D-5L, and SF-6D utilities in patients with different musculoskeletal (MSK) disorders, also differing in disease severity as defined by valid clinical indexes.
Kontodimopoulos N, Stamatopoulou E, Gazi S, Moschou D, Krikelis M, Talias MA.   +5 more
europepmc   +2 more sources

A systematic review of SF-6D health state valuation studies

Journal of Medical Economics, 2023
Background The short-form 6-dimension (SF-6D) is a preference-based measure designed to calculate quality-adjusted life-year (QALY). Preference-based measures are standardized multidimensional health state classifications with preference or utility ...
Liang Wang, T. Poder
semanticscholar   +3 more sources

Mapping the obesity problems scale to the SF-6D: results based on the Scandinavian Obesity Surgery Registry (SOReg). [PDF]

Eur J Health Econ, 2023
Background Obesity Problem Scale (OP) is a widely applied instrument for obesity, however currently calculation of health utility based on OP is not feasible as it is not a preference-based measure .
Sun S, Stenberg E, Cao Y, Lindholm L, Salén KG, Franklin KA, Luo N.   +6 more
europepmc   +2 more sources

Health utility measurement for people living with HIV/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D. [PDF]

Medicine (Baltimore), 2022
We compared the discriminative validity, agreement and sensitivity of EQ-5D-5L and SF-6D utility scores in people living with HIV/AIDS (PLWHIV). We conducted a cross-sectional survey among PLWHIV aged more than 18 years old in 9 municipalities in Yunnan ...
Wang X, Luo H, Yao E, Tang R, Dong W, Liu F, Liang J, Xiao M, Zhang Z, Niu J, Song L, Fu L, Li X, Qian S, Guo Q, Song Z.   +15 more
europepmc   +2 more sources

SF-6D Normative Values Among Patients Undergoing Bariatric Surgery: Results Based on Real-World Evidence from the Scandinavian Obesity Surgery Registry (SOReg). [PDF]

Obes Surg
The SF-6D index can be used to calculate quality-adjusted life years in economic evaluations, which is required by reimbursement agencies and national advisory bodies, including the Swedish ones. However, despite that SF-36 has been largely applied among
Sun S, Stenberg E, Luo N, Franklin KA, Lindholm L, Salén KG, Cao Y.   +6 more
europepmc   +2 more sources

Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D. [PDF]

Eur J Health Econ, 2023
BACKGROUND The EQ-5D and the SF-6D are examples of commonly used generic preference-based instruments for assessing health-related quality of life (HRQoL). However, their suitability for mental disorders has been repeatedly questioned.
Stolz M, Albus C, Beutel ME, Deter HC, Fritzsche K, Herrmann-Lingen C, Michal M, Petrowski K, Ronel J, Schultz JH, Söllner W, Weber C, de Zwaan M, Krauth C.   +13 more
europepmc   +2 more sources

SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration. [PDF]

PLoS ONE, 2017
Economic evaluations in wet age-related macular degeneration (ARMD) is hampered as often utility values for solely one eye are used, mostly the better-seeing eye (BSE).
Martijn S Visser, Sankha Amarakoon, Tom Missotten, Reinier Timman, Jan J Busschbach   +4 more
doaj   +13 more sources

A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population. [PDF]

Pharmacoeconomics, 2021
This paper describes the first evaluation of the construct validity and performance of the newly developed preference-based measure of health, the SF-6D version 2 (SF-6Dv2). Utilising data from the Multi-Instrument Comparison (MIC) project (n = 7932), we
McDool E, Mukuria C, Brazier J.
europepmc   +2 more sources

Comparing the Performance of the SF-6D and the EQ-5D in Different Patient Groups [PDF]

Acta Médica Portuguesa, 2014
Introduction: This research aims to explore the performance of the SF-6D and the EQ-5D in patients suffering from asthma, chronic obstructive pulmonary disease, cataracts, and rheumatoid arthritis.
Lara N. Ferreira, Pedro L. Ferreira, Luis N. Pereira   +2 more
doaj   +3 more sources